A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE.
about
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors.The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.Practical aspects of extended half-life products for the treatment of haemophilia
P2860
A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A world-wide survey and field ...... ZUR in comparison with ADVATE.
@en
A world-wide survey and field ...... ZUR in comparison with ADVATE.
@nl
type
label
A world-wide survey and field ...... ZUR in comparison with ADVATE.
@en
A world-wide survey and field ...... ZUR in comparison with ADVATE.
@nl
prefLabel
A world-wide survey and field ...... ZUR in comparison with ADVATE.
@en
A world-wide survey and field ...... ZUR in comparison with ADVATE.
@nl
P2093
P2860
P356
P1433
P1476
A world-wide survey and field ...... IZUR in comparison with ADVATE
@en
P2093
A Crocker-Buqué
P L Turecek
S Romeder-Finger
P2860
P304
P356
10.1111/HAE.13001
P577
2016-06-28T00:00:00Z